3-Methyl-5-(piperazin-1-yl)-1,2-thiazole-4-carbonitrile

Catalog No.: 
ACYTKJ244
CAS No.: 
1803592-90-6
Molecular Formula: 
C9H12N4S
Molecular Weight: 
208.29
3-Methyl-5-(piperazin-1-yl)-1,2-thiazole-4-carbonitrile structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
50mg95%$290.00InquiryInquiry
100mg95%$424.00InquiryInquiry
250mg95%$598.00InquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name3-Methyl-5-(piperazin-1-yl)-1,2-thiazole-4-carbonitrile
IUPAC Name3-methyl-5-(piperazin-1-yl)isothiazole-4-carbonitrile
MDL No.MFCD28714521
Molecular FormulaC9H12N4S
Molecular Weight208.29
SMILESN#CC1=C(N2CCNCC2)SN=C1C
InChI KeyBVFBJODHCIYRQL-UHFFFAOYSA-N
Synonym3-methyl-5-(piperazin-1-yl)-1,2-thiazole-4-carbonitrile;4-Isothiazolecarbonitrile, 3-methyl-5-(1-piperazinyl)-
CAS No.1803592-90-6

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P280-P301+P312-P302+P352-P305+P351+P338

Synthetic Route by SureRoute

1. ACYTKJ244 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACEUMO414 route compound structure diagram
    ACEUMO41459813-05-7
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACYTKJ244 route product structure diagram
    ACYTKJ2441803592-90-6
Inquiry

2. ACYTKJ244 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACEUMO414 route compound structure diagram
    ACEUMO41459813-05-7
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACYTKJ244 route product structure diagram
    ACYTKJ2441803592-90-6
Inquiry

3. ACYTKJ244 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACYTKJ244 route product structure diagram
    ACYTKJ2441803592-90-6
Inquiry

Comments (0)